← Back to Search

Other

3000-mg cohort for Campylobacteriosis

Phase 2
Waitlist Available
Led By Mohamed Al-Ibrahim, MB,ChB, FACP
Research Sponsored by Lumen Bioscience, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial tests a new drug, LMN-101, to see if it can prevent or reduce the severity of an infection with the bacteria Campylobacter jejuni.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of solicited or unsolicited adverse events
Secondary outcome measures
Campylobacter
Proportion of subjects with specific solicited adverse events

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 3000-mg cohortActive Control1 Intervention
LMN-101, six 500-mg capsules orally three times daily for 14 days (n=21)
Group II: Placebo cohortPlacebo Group1 Intervention
Placebo, six 500-mg capsules orally three times daily for 14 days (n=21)

Find a Location

Who is running the clinical trial?

Naval Medical Research CenterFED
33 Previous Clinical Trials
2,858 Total Patients Enrolled
University of MarylandOTHER
160 Previous Clinical Trials
302,241 Total Patients Enrolled
Lumen Bioscience, Inc.Lead Sponsor
4 Previous Clinical Trials
443 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
LMN-101 in a Campylobacter Human Challenge Model
2022. "LMN-101 in a Campylobacter Human Challenge Model". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04182490.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top